Evaluating SARS-CoV-2 Antibody Resilience via Prediction and Design of Escape Viral Variants
Preprint
Abstract
SUMMARY: The evolutionary trajectory of SARS-CoV-2 is shaped by competing pressures for ACE2 binding, viability, and escape from neutralizing antibodies targeting its receptor-binding domain (RBD). Here, we present EscapeMap, a modular framework that enables prediction and design of variants escaping antibodies. EscapeMap integrates deep mutational scanning data for ACE2 and 31 monoclonal antibodies with a generative sequence model trained on pre-pandemic Coronaviridae. To experimentally probe escape potential, we designed RBD variants under pressure from four clinically relevant antibodies (SA55, S2E12, S309, VIR-7229). Among these designs, bearing up to 21 mutations from wildtype, 50% expressed as stable proteins. Binding assays confirm that S309 and VIR-7229 retain recognition across diverse mutation combinations. EscapeMap accurately forecasts which antibodies are vulnerable to escape by our designed sequences. Finally, by identifying correlated escape routes, we predict and experimentally verify, antibody combinations less prone to simultaneous escape, offering a quantitative basis for guiding therapeutic strategies.Keywords
This publication has 68 references indexed in Scilit:
- A potent pan-sarbecovirus neutralizing antibody resilient to epitope diversificationCell, 2024
- Broad sarbecovirus neutralization by combined memory B cell antibodies to ancestral SARS-CoV-2iScience, 2024
- Population immunity predicts evolutionary trajectories of SARS-CoV-2Cell, 2023
- Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariantsCell, 2022
- Rational identification of potent and broad sarbecovirus-neutralizing antibody cocktails from SARS convalescentsCell Reports, 2022
- Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serumCell, 2022
- Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016Cell Reports Medicine, 2021
- Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodiesCell Host & Microbe, 2021
- Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody RecognitionCell Host & Microbe, 2021
- Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 BindingCell, 2020